A draft science report on Interventions for Obstructive Sleep Apnea is now available for feedback from all interested stakeholders.
Project
Call for Feedback
Feedback Due By
Interventions for Obstructive Sleep Apnea
2016-10-19
2016-11-02
Consultation Document
Product Type
Submit Stakeholder…
Register today for a thought-provoking and highly engaging talk by Dr. Tom Noseworthy, one of the most respected figures in Canadian health care. In his CADTH lecture, Dr. Noseworthy calls the entry, exit, and scope of use of health technologies “a sleeping giant begging attention” and shares his…
The agendas are now available for the CADTH Drug Portfolio Information Sessions, which will be held on October 26, 2016, at the Allstream Centre in Toronto.
The sessions are an opportunity for CADTH to engage with key stakeholders, provide program updates and other information, and hear directly…
CADTH is looking for volunteers to review abstracts submitted for presentation at the 2017 CADTH Symposium. This is a great way to participate in developing a stellar program, featuring relevant and engaging topics in a wide variety of formats: workshops, oral presentations, poster presentations,…
We are pleased to announce that nominations are now being accepted for two prestigious awards for outstanding achievement in the field of health technology assessment (HTA) in Canada.
The Dr. Jill M. Sanders Award of Excellence in Health Technology Assessment recognizes individuals whose…
Earlier this month, Alberta Health used evidence produced by CADTH to help inform changes in how it covers proton pump inhibitors (PPIs) — a type of medication used to treat stomach and digestive problems.
Our detailed review of PPIs showed that all medications for acid reflux conditions, both…
CADTH is pleased to announce the 2017 CADTH Symposium Travel Award Program for students and patient group representatives.
Since 2007, CADTH has provided financial support toward conference-related costs for more than 190 student and patient group representatives as part of our commitment to…
CADTH is pleased to announce the appointment of Trevor Richter as Director, CADTH Common Drug Review (CDR) and Optimal Use of Drugs, effective October 10, 2016.
Reporting to Brent Fraser, Vice-President of Pharmaceutical Reviews, Trevor will be responsible for CADTH’s non-oncology drug reviews and…
Read this month’s issue of New at CADTH. Here, you’ll find the latest information on our products and services, corporate news, and news flashes of upcoming events across Canada.
A draft version of the updated Guidelines for the Economic Evaluation of Health Technologies: Canada (4th Edition) will be available for stakeholder feedback from October 28 through November 25, 2016.
As per standard CADTH procedure, an invitation for feedback will be posted on our website at www.…
The 2017 CADTH Symposium Program Committee invites submissions of abstracts for workshops, panels, breakfast sessions, and oral and poster presentations, related to the theme of Measuring Value in Theory and the Real World.
Abstracts must be submitted online at Call for Abstracts.
Submission…
Stakeholder Feedback on the New Therapeutic Review Framework and Process
Background
On June 25, 2015, CADTH posted a revised Therapeutic Review Framework and Process document for stakeholder feedback. The Therapeutic Review Framework was first developed in 2012, and since this time, various changes…